ENDONOVO THERAPEUTICS, INC. (ENDV) › Shares OutstandingENDONOVO THERAPEUTICS, INC. (ENDV) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2011: 38.31M2012: 53.69M2013: 832.2K2014: 81.43M2015: 104.80M2016: 134.34M2017: 316.95M2018: 431.1K2019: 1.19M2020: 24.54M2021: 74.50M2022: 213.23M213.23M2011Shares Outstanding (shares)2022Fiscal YearShares OutstandingChange YoY2022213.23M+186.2%202174.50M+203.6%202024.54M+1963.3%20191.19M+175.9%2018431.1K-99.9%2017316.95M+135.9%2016134.34M+28.2%2015104.80M+28.7%201481.43M+9684.2%2013832.2K-98.5%201253.69M+40.1%201138.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share